DA Davidson analyst Linda Bolton Weiser downgrades Medifast (NYSE:MED) from Buy to Neutral and lowers the price target from $278 to $106.
5 Value Stocks In The Consumer Cyclical Sector
What are Value Stocks? A value stock is traditionally defined in terms of how investors in the marketplace…